 - Patients must have no evidence of significant hematologic, renal, or hepatic dysfunction; patients with underlying hepatocellular disease should be given careful riskbenefit consideration prior to enrollment; patients with a history of any chronic hepatitis as evidenced by the following are ineligible: 